Flawless Beauty's Relaunch Pending As Injunction-Mandated Recall Starts
This article was originally published in The Rose Sheet
"We didn't want to fight this any further because of the legal fees," said Jack Gindi, owner of the firm. Four months after it agreed to within 20 days recall all lots of 19 products that FDA said were injectable or that contained human placenta, supplement and cosmetic firm Flawless Beauty on Jan. 23 announced the recall.
You may also be interested in...
FDA warns Smart Toothpicks about selling nicotine-infused toothpicks to a minor and its online claim, "nicotine satisfaction without smoke damage to your lungs.” Escaping FDA attention so far are a dry mouth claim and a B12 formulation.
Ocean Township, N.J.-based Flawless Beauty has been on FDA's radar since 2013, targeted with two facility inspections and a previous complaint that triggered product seizures by US Marshals. Unapproved skin-whitening injectables sold by the company pose potential serious health risks, according to a New Jersey District Court consent decree of permanent injunction against the company and its owners.
A growing number of injectable skin-whitening products are available to consumers through online retailers and other channels, FDA says in an update cautioning the public that such products could pose "significant" safety risks. The agency singles out Flawless Beauty, LLC, which has been subject to recent enforcement activity, including product seizure by U.S. Marshals, but continues to market questionable skin-whitening products with aggressive claims.